U.S. Markets open in 6 hrs 51 mins

Oncolytics Biotech (ONCY)Soars: Stock Up 6.3%

Zacks Equity Research

Oncolytics Biotech Inc. (ONCY) was a big mover last session, as its shares rose over 6% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent uptrend for the company, as the stock is now trading above the volatile price range of $1.54 to $1.81 in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Oncolytics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gentium S.p.A (GENT), Emergent BioSolutions, Inc. (EBS) and Actelion Ltd. (ALIOF). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




ONCOLYTICS BIOTECH INC (ONCY): Free Stock Analysis Report

GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report

EMERGENT BIOSOLUTIONS INC (EBS): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report


Zacks Investment Research